Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Sterile, non-pyrogenic bacteriostatic water for injection 0.9% benzyl alcohol, 30 mL multi-dose vial
In REDEFINE 1 (NEJM 2025, n=3,417, 68 weeks), cagrilintide monotherapy at 2.4 mg produced 11.8% mean body-weight reduction versus 2.3% with placebo
(PubMed) Mills JL, Scott JM, Kirke PN, et al
Contraindications: Not for use in individuals with cancer, during pregnancy/breastfeeding, or those under 18
Injectable treatment may help support the bodys natural antioxidant defenses when clinically appropriate
US$ 20.14
US$ 25.56
.png)
US$ 20.77
US$ 29.47
US$ 25.36
US$ 27.54
US$ 26.57
